Millmount re-qualify Navan facility

Millmount announces high-potent packaging capabilities

Millmount Healthcare have completed the re-qualification of their Navan manufacturing facility. The site will now be dedicated to the handling of high-potent drugs for one of Millmount's main pharmaceutical partners.

The addition of the high-potent facility is the result of a major capital investment and expansion of services on the part of the Irish-based company. Previously, Millmount has focused its efforts on providing contract packaging services to generic and ethical solid dosage manufacturers in Ireland and across the Eurozone.

The Navan facility has the capacity to run approximately 2 million tablets per shift, per week, with Millmount catering for economic run sizes starting from as little as several hundred packs.

"The dedicated high-potent facility in Navan allows Millmount to provide cGMP contract packaging services for pharmaceutical compounds such as enzymes and antibiotics", said Pascal Keogh, Millmount's Managing Director.

"Our expansion into high-potent packaging further supports the commitment at the company to service the biopharmaceutical industry. More and more companies are searching for state-of-the-art outsourcing services. Whether they require outsourced packaging for their finished-dosage forms or as part of their clinical / stability studies, we can cater to their needs and more."

The high-potent packaging facility at Millmount features an HVAC system designed for 20 room air changes per hour, utilising HEPA filtration to eliminate any possibility of cross-contamination. Personnel airlocks, along with a separate equipment and materials airlock provide full  containment of compounds. The Navan facility also has a dedicated control system to monitor and regulate the environmental conditions of the packaging suites.

For more information on the high-potent pharmaceutical packaging services available at Millmount Healthcare, please contact us.